Amy When

Contact Amy

Amy When

Executive Director and Distinguished Scientist, Companion Diagnostics

Merck

Expertise in development, implementation, and oversight of biomarker-driven clinical trial assays for patient enrollment. Responsible for development of strategy for global companion diagnostic (CDx) submissions. Served as scientific lead for cross-functional CDx development teams within device companies and large pharma. Experienced with both analytical and clinical validation strategies leading to multiple complex global CDx approvals (pan-tumor, multi-gene biomarkers, and genomic signatures). Supported clinical team strategies on multiple biomarker-driven global drug filings as SME.

Talks About
#management #commucations

Preferred Locations
#Northamerica

Speaking Engagements

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Paid

Leveraging next gen technologies beyond conventional biomarker drug discovery! MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

08-09 February 2023

Healthcare

MarketsandMarkets Biomarker and Companion Diagnostics Conference-East Coast Edition

Paid

The Biomarker and Companion Diagnostics Conference, organized by MarketsandMarkets, is set to take place on the 22nd and 23rd of June 2023 in Boston, USA. The event aims to explore how next-generation technologies can be used to advance biomarker drug discovery beyond conventional methods.

The conference will feature presentations by over 30

22-23 June 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Amy When

Executive Director and Distinguished Scientist, Companion Diagnostics

Speaking Engagements

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

MarketsandMarkets Biomarker and Companion Diagnostics Conference-East Coast Edition